Intellectual Property Rights

9 November 2016 – WTO TRIPS Council – Holy See’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, H.E. Archbishop Ivan Jurkovic, (Holy See) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by H.E. Archbishop Ivan Jurkovic , Permanent Observer of the Holy See to the United Nations and Other International Organizations in Geneva at the World Trade Organization (WTO) Trade Related Intellectual Property Rights (TRIPs) Council, Geneva, 9 November 2016

Mr. President,

Continue Reading →

9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.

The Report of the United Nations High Level Panel on Access to Medicine
Continue Reading →

9 November 2016 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, India delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

Agenda item 13: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by India.

Thank you Chairman.

At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.

Continue Reading →

9 November 2016 – WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

COUNCIL FOR TRIPS

8-9 NOVEMBER 2016

WHO STATEMENT

13. THE UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES

Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.

Continue Reading →

9 November 2016 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On 9 November 2016, the World Trade Organization’s (WTO) TRIPS Council held discussions on the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines (UN HLP). These timely WTO discussions on the UN HLP germinated from a 27 October 2016 request by Brazil, China, India and South Africa requesting the WTO Secretariat to place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.”

Continue Reading →

WTO TRIPS Council – Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines

Posted on by Staff

On Thursday, 27 October 2016, Brazil, China, India and South Africa submitted a communication (IP/C/W/619) to the World Trade Organization (WTO) requesting the WTO Secretariat to “place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.” In the WTO submission, Brazil, China, India and South Africa enclosed the entire Final Report of the UN Secretary-General’s High-Level Panel on Access to Continue Reading →

WIPO General Assembly 2016: Opening Statement of Knowledge Ecology International

Posted on by KEI Staff

On October 4th, 2016, Knowledge Ecology International (KEI) delivered this opening statement on the occasion of the Fifty-Sixth Series of Meetings of the Assemblies of the Member States of the World Intellectual Property Organization (WIPO).


KEI General Statement – WIPO General Assembly – 2016

October 4th, 2016

Thank you Chair for providing Knowledge Ecology International (KEI) the opportunity to speak today.

Continue Reading →

National Association of Manufacturers told USTR the EU position on LDC extension made a mockery of international trading system

Posted on by Thiru

On September 10, 2015, the National Association of Manufacturers (NAM), wrote to USTR expressing alarm at the European Union support of an indefinite extension of a WTO waiver of obligations to grant patents on pharmaceuticals for UN defined least developed countries (LDCs). In 2015, there were 954 million persons living in LDCs, with a per capita income of $964, according to the World Bank. The EU had aligned itself with health advocates trying to protect the bottom billion access to life saving medicines.

Continue Reading →

KEI Statement on United Nations Secretary-General’s High-Level Panel on Access to Medicines Report

Posted on by KEI Staff

On September 14, 2016, the United Nations Secretary-General’s High-Level Panel on Access to Medicines issued its long-awaited report, which addressed the policy incoherencies between intellectual property, trade, human rights, innovation, and public health.

The report is available here: http://www.unsgaccessmeds.org/final-report/
Continue Reading →